Optimized for Therapeutic Success
Refined for efficacy, and for manufacturing at scale.
02/
OmniParticles refines complex nanomedicine formulations from mock-up to a medicine-ready nanoparticle, with expertise across both organic and inorganic systems. Our proprietary INNOSURFACE® platform integrates therapeutic cores (small molecules, proteins and nanozymes) with biocompatible polymers, lipids and silica through in-situ surface engineering, keeping quality consistent from lab scale to commercial production.
Photos of formulation lab at OmniParticles
What we offer
1
Suggestion from mock-up drug design
Tailored formulation strategies that enhance efficacy, bioavailability, stability and scalability while meeting regulatory and clinical requirements.
2
Prototype optimization
Systematic refinement of therapeutic ingredients and excipients to improve solubility, dispersion and controlled release.
3
Scalability & manufacturability
Key process parameters evaluated early, so the formulation moves efficiently from laboratory scale to clinical production.
4
Characterization (prototype / client's design)
Size, morphology, surface charge and drug release kinetics analyzed for in-house prototypes or client-provided designs, ensuring every critical quality attribute (CQA) is met before scale-up.
5
Broad nanoparticle coverage
Metal and metal-oxide cores (gold, silver, iron oxide, cerium oxide, silica and more), polymers (PLGA, PLA, PCL, PEG, chitosan) and lipid systems (liposomes, SLNs, NLCs), carrying small molecules, proteins, antibodies and nucleic acids, including our ICONPLEX™ mesoporous silica platform with pore sizes tunable from 2 to 30 nm.